8 research outputs found
Conserved presence of G-quadruplex forming sequences in the Long Terminal Repeat Promoter of Lentiviruses
G-quadruplexes (G4s) are secondary structures of nucleic acids that epigenetically regulate cellular processes. In the human immunodeficiency lentivirus 1 (HIV-1), dynamic G4s are located in the unique viral LTR promoter. Folding of HIV-1 LTR G4s inhibits viral transcription; stabilization by G4 ligands intensifies this effect. Cellular proteins modulate viral transcription by inducing/unfolding LTR G4s. We here expanded our investigation on the presence of LTR G4s to all lentiviruses. G4s in the 5'-LTR U3 region were completely conserved in primate lentiviruses. A G4 was also present in a cattle-infecting lentivirus. All other non-primate lentiviruses displayed hints of less stable G4s. In primate lentiviruses, the possibility to fold into G4s was highly conserved among strains. LTR G4 sequences were very similar among phylogenetically related primate viruses, while they increasingly differed in viruses that diverged early from a common ancestor. A strong correlation between primate lentivirus LTR G4s and Sp1/NF\u3baB binding sites was found. All LTR G4s folded: their complexity was assessed by polymerase stop assay. Our data support a role of the lentiviruses 5'-LTR G4 region as control centre of viral transcription, where folding/unfolding of G4s and multiple recruitment of factors based on both sequence and structure may take place
A core extended naphtalene diimide G-quadruplex ligand potently inhibits herpes simplex virus 1 replication
G-quadruplexes (G4s) are nucleic acids secondary structures, epigenetic regulators in cells and viruses.
In herpes simplex virus 1 (HSV-1)-infected cells, G4s are massively present during viral replication. We
here aimed at investigating the possibility to target the HSV-1 G4s by a core extended naphtalene
diimide (c-exNDI) G4 ligand. Biophysical and biomolecular analysis proved that c-exNDI stabilized the
HSV-1 G4s in a concentration dependent manner. In MS competition assays, c-exNDI preferentially
recognized HSV-1 G4s over cellular telomeric G4s, the most represented G4s within cells; other less
abundant cellular G4s were also recognized. Treatment of HSV-1 infected cells with c-exNDI at low
nanomolar concentrations induced significant virus inhibition with no cytotoxicity. The mechanism of
action was ascribed to G4-mediated inhibition of viral DNA replication, with consequent impairment
of viral genes transcription. Our data suggest that the observed potent antiviral activity and low
cytotoxicity mainly depend on a combination of c-exNDI affinity for HSV-1 G4s and their massive
presence during infection. HSV-1 G4s may thus represent new effective antiviral targets: the fact that
no current antiherpetic drug exploits them and their presence at the viral genome, responsible for both
active and latent HSV infections, makes them particularly attracting